Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Management of toxicities due to immune checkpoint inhibitors.
Journal: Clinical advances in hematology & oncology : H&O
Published: August 04, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.
Journal: Journal for immunotherapy of cancer
Published: May 11, 2026
The management of rheumatic immune related adverse events.
Journal: Best practice & research. Clinical rheumatology
Published: December 05, 2025
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study.
Journal: Annals of the rheumatic diseases
Published: November 11, 2025
Real-World Analysis of Patient Characteristics, Adverse Events, and Economic Burden Among Patients with Giant Cell Arteritis Treated with Glucocorticoids.
Journal: Rheumatology and therapy
Published: April 07, 2025
Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis.
Journal: Arthritis care & research
Published: April 01, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 06, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk.
Journal: JAMA network open
Published: November 20, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 13, 2024
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis.
Journal: Frontiers in immunology
Published: September 20, 2024
Immunotherapy Toxicity Management in Clinical Practice: Building the Clinical Infrastructure for Immune-related Adverse Event Evaluation and Care.
Journal: Rheumatic diseases clinics of North America
Published: April 26, 2024
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis.
Journal: Rheumatic diseases clinics of North America
Published: April 26, 2024
Last Updated: 09/26/2026